Shahrokh Shariat, Professor and Chairman of the Department of Urology, Director of the Comprehensive Cancer Center shared on LinkedIn:
“An important step forward for men’s health! Congratulations to the American Cancer Society on its updated prostate cancer screening recommendations.
The guidance now recommends a PSA blood test every two years for men aged 50-69 at average risk, with earlier and more frequent testing for certain higher-risk groups.
An elevated PSA should first be confirmed. MRI and other tests can then help determine who needs a biopsy. Men with low-risk cancer should be offered active surveillance, helping them avoid or delay unnecessary treatment.
The aim is clear: find dangerous cancers earlier, reduce advanced disease and prevent deaths while limiting harm.
I hope this gives Austria further momentum to introduce organized, risk-adapted prostate cancer screening accessible to all eligible men.
Men and their families deserve timely action.
You can also read: New Prostate Cancer Screening Guidelines Recommend Regular PSA Testing
